Page last updated: 2024-09-03

gefitinib and Heart Diseases

gefitinib has been researched along with Heart Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, YY; Xue, FT; Yang, J; Yu, XF; Zhang, S	1

Other Studies

2 other study(ies) available for gefitinib and Heart Diseases

Article	Year
Decreased HSP70 expression on serum exosomes contributes to cardiac fibrosis during senescence. European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:9 Topics: Aging; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Connective Tissue Growth Factor; Exosomes; Fibrosis; Gefitinib; Heart Diseases; HSP70 Heat-Shock Proteins; Male; Myocardium; Myofibroblasts; Rats; Rats, Sprague-Dawley; Thrombospondin 1; Transforming Growth Factor beta1	2019
Expect the unexpected. The Lancet. Oncology, 2006, Volume: 7, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Gefitinib; Heart Diseases; Humans; Multiple Organ Failure; Neoplasms; Pneumonia; Quinazolines	2006

Article

Year

Decreased HSP70 expression on serum exosomes contributes to cardiac fibrosis during senescence.

European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:9

Topics: Aging; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Connective Tissue Growth Factor; Exosomes; Fibrosis; Gefitinib; Heart Diseases; HSP70 Heat-Shock Proteins; Male; Myocardium; Myofibroblasts; Rats; Rats, Sprague-Dawley; Thrombospondin 1; Transforming Growth Factor beta1

2019

Expect the unexpected.

The Lancet. Oncology, 2006, Volume: 7, Issue:5

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Gefitinib; Heart Diseases; Humans; Multiple Organ Failure; Neoplasms; Pneumonia; Quinazolines

2006